A Transgenic Model for Portal Hypertension and VEGF Regulation
Author Information
Author(s): May Dalit, Djonov Valentin, Zamir Gideon, Bala Miklosh, Safadi Rifaat, Sklair-Levy Miriam, Keshet Eli
Primary Institution: The Hebrew University–Hadassah University Hospital, Jerusalem, Israel
Hypothesis
Is Vascular Endothelial Growth Factor (VEGF) essential for maintaining the structure and function of liver sinusoidal endothelial cells?
Conclusion
The study found that VEGF is crucial for maintaining sinusoidal fenestrations, and its blockade leads to portal hypertension, which can be reversed by restoring VEGF function.
Supporting Evidence
- VEGF blockade resulted in closure of sinusoidal endothelial cell fenestrations.
- Sinusoidal capillarization was sufficient to cause portal hypertension without parenchymal damage.
- Restoration of VEGF function reversed portal hypertension and its secondary complications.
Takeaway
This study shows that a protein called VEGF helps keep blood vessels in the liver open, and when it's blocked, it can cause serious problems like high blood pressure in the liver, but these problems can go away if VEGF is turned back on.
Methodology
The study used a transgenic mouse model to conditionally induce and block VEGF signaling in the liver, allowing for reversible manipulation of VEGF function.
Limitations
The study does not provide evidence that loss of VEGF function is an etiological factor in clinical settings of portal hypertension.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website